Chemoinformaics analysis of Glaucarubol 15-O-beta-D-glucopyranoside
Molecular Weight | 558.577 | nRot | 3 |
Heavy Atom Molecular Weight | 520.273 | nRig | 30 |
Exact Molecular Weight | 558.231 | nRing | 6 |
Solubility: LogS | -1.82 | nHRing | 3 |
Solubility: LogP | -1.454 | No. of Aliphatic Rings | 6 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 0 |
nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
nHA | 13 | APOL | 79.1841 |
nHD | 8 | BPOL | 45.9339 |
QED | 0.126 |
Synth | 6.89 |
Natural Product Likeliness | 3.732 |
NR-PPAR-gamma | 0.056 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0.988 |
HIA | 0.981 |
CACO-2 | -6.241 |
MDCK | 0.000276322 |
BBB | 0.101 |
PPB | 0.296548 |
VDSS | 0.368 |
FU | 0.488749 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.096 |
CYP2c19-inh | 0.001 |
CYP2c19-sub | 0.133 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.077 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.116 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.024 |
CL | 1.173 |
T12 | 0.112 |
hERG | 0.005 |
Ames | 0.147 |
ROA | 0.168 |
SkinSen | 0.005 |
Carcinogencity | 0.013 |
EI | 0.003 |
Respiratory | 0.102 |
NR-Aromatase | 0.016 |
Antiviral | Yes |
Prediction | 0.803123 |